These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1087994)

  • 1. Membrane cell markers in human leukemias and lymphomas.
    Seligmann M
    Ric Clin Lab; 1976; 6(2):93-8. PubMed ID: 1087994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: B-cell and T-cell markers in lymphoid proliferations.
    Seligmann M
    N Engl J Med; 1974 Jun; 290(26):1483-4. PubMed ID: 4598692
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel human T cell antigen preferentially expressed on mature T cells and shared by both well and poorly differentiated B cell leukemias and lymphomas.
    Kamoun M; Kadin ME; Martin PJ; Nettleton J; Hansen JA
    J Immunol; 1981 Sep; 127(3):987-91. PubMed ID: 6790625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological characterization of lymphoproliferative disorders by membrane markers.
    Huber H; Michlmayr G; Huber C; Falkensammer M
    Klin Wochenschr; 1976 Aug; 54(15):699-708. PubMed ID: 790006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic characterization and ultrastructural correlations for 125 cases of B- and T-cell leukemias: studies of chronic and acute lymphocytic, prolymphocytic, lymphosarcoma cell and hairy cell leukemia, Sézary's syndrome, and other lymphoid leukemias.
    Said JW; Pinkus GS
    Cancer; 1981 Dec; 48(12):2630-42. PubMed ID: 6975649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique cell surface antigen identifying lymphoid malignancies of B cell origin.
    Nadler LM; Ritz J; Hardy R; Pesando JM; Schlossman SF; Stashenko P
    J Clin Invest; 1981 Jan; 67(1):134-40. PubMed ID: 6969730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of T and B lymphocyte membrane markers in human non-Hodgkin malignant lymphomata.
    Brouet JC; Labaume S; Seligmann M
    Br J Cancer Suppl; 1975 Mar; 2():121-7. PubMed ID: 1081001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-T, non-B lymphomas are rare in childhood and associated with cutaneous tumor.
    Bernard A; Murphy SB; Melvin S; Bowman WP; Caillaud J; Lemerle J; Boumsell L
    Blood; 1982 Mar; 59(3):549-54. PubMed ID: 6977384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.
    Ritz J; Nadler LM; Bhan AK; Notis-McConarty J; Pesando JM; Schlossman SF
    Blood; 1981 Sep; 58(3):648-52. PubMed ID: 6973348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The heterogeneity of human lymphoid leukemias unmasked by immunological studies of membrane markers (author's transl)].
    Seligmann M; Brouet JC; Preud'homme JL
    Nouv Rev Fr Hematol Blood Cells; 1977; 18(2):339-50. PubMed ID: 303356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane antigen analysis in the diagnosis of lymphoid leukemias and lymphomas. Differential diagnosis, prognosis as related to immunophenotype, and recommendations for testing.
    Deegan MJ
    Arch Pathol Lab Med; 1989 Jun; 113(6):606-18. PubMed ID: 2658905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [On the cell surface markers of lymphocytes in lymphoproliferative disorders (author's transl)].
    Tanaka E
    Rinsho Ketsueki; 1976 Jun; 17(6):600-17. PubMed ID: 823349
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoclonal antibody against a membrane antigen characterizing leukemic human B-lymphocytes.
    Forster HK; Gudat FG; Girard MF; Albrecht R; Schmidt J; Ludwig C; Obrecht JP
    Cancer Res; 1982 May; 42(5):1927-34. PubMed ID: 6175400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical demonstration of cell surface antigens on tissue sections of lymphomas.
    Hoffmann-Fezer G; Thierfelder S; Pielsticker K; Rodt H
    Leuk Res; 1979; 3(5):297-304. PubMed ID: 392200
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies with multiple markers on malignant lymphomas and lymphoid leukemias.
    Watanabe S; Shimosato Y; Shimoyama M; Minato K
    Cancer; 1982 Dec; 50(11):2372-82. PubMed ID: 6982748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and hematological heterogeneity of T-cell derived lymphoproliferative diseases.
    Brouet JC; Flandrin G
    Bull Cancer; 1977; 64(2):267-74. PubMed ID: 143976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunopathology of non-Hodgkin lymphomas.
    Huber H; Gattringer C; Knapp W; Stein H
    Klin Wochenschr; 1984 Nov; 62(21):1001-10. PubMed ID: 6392723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
    Stein H
    Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of an antigen associated with acute lymphoblastic leukemia in human leukemia-lymphoma cell lines.
    Minowada J; Janossy G; Greaves MF; Tsubota T; Srivastava BI; Morikawa S; Tatsumi E
    J Natl Cancer Inst; 1978 Jun; 60(6):1269-77. PubMed ID: 206705
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.